JPRN-UMIN000004583已完成未知
Clinical study to investigate recurrence efficacy on a combined use of radiofrequency ablation therapy and auto-gamma/delta T cell therapy for hepatitis C virus-related hepatocellular carcinoma patients. - Clinical study to investigate recurrence efficacy on a combined use of radiofrequency ablation therapy and auto-gamma/delta T cell therapy for hepatitis C virus-related hepatocellular carcinoma patients.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have: - Active enteritis; - Active autoimmune diseases; - Active infections; - Other cancers; - Other serious complications; - Continuous systemic administration of steroids.
研究者
相似试验
招募中
3 期
A confirmatory clinical study of ISN001 in patients with epidermolysis bullosaJPRN-jRCT2033210128Ishiko Akira8
进行中（未招募）
不适用
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects with Irritable Bowel Syndrome with Diarrhoea (IBS-D)Irritable bowel syndrome (IBS) is a heterogeneous gastrointestinal (GI) disorder characterized by frequent and debilitating symptoms (e.g. diarrhoea, bloating, abdominal pain, urgency to defecate, gas, faecal incontinence). A distinct feature of the disorder is the often cyclical waxing and waning of various symptoms. There remains a significant unmet need for effective and safe therapies, particularly for IBS with diarrhoea (IBS-D).MedDRA version: 14.1Level: LLTClassification code 10060849Term: Diarrhoea predominant irritable bowel syndromeSystem Organ Class: 100000004856EUCTR2013-002394-22-DESalix Pharmaceuticals, Inc.800
进行中（未招募）
1 期
A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects with Irritable Bowel Syndrome with Diarrhoea (IBS-D)Irritable bowel syndrome (IBS) is a heterogeneous gastrointestinal (GI) disorder characterized by frequent and debilitating symptoms (e.g. diarrhoea, bloating, abdominal pain, urgency to defecate, gas, faecal incontinence). A distinct feature of the disorder is the often cyclical waxing and waning of various symptoms. There remains a significant unmet need for effective and safe therapies, particularly for IBS with diarrhoea (IBS-D).MedDRA version: 16.0 Level: LLT Classification code 10060849 Term: Diarrhoea predominant irritable bowel syndrome System Organ Class: 100000004856EUCTR2013-002394-22-GBSalix Pharmaceuticals, Inc.800
尚未招募
不适用
Study for evaluating clinical efficacy of a recreation program to improve cognitive abilities of elderly people in day care center using eye-tracking-based cognitive assessment.Mild cognitive impairmentJPRN-UMIN000046276Osaka university120
已完成
2 期
A Clinical study on cervical spondylosis using thengaai thuruval ottradam (external therapy)CTRI/2021/02/031542Government Siddha medical college and hospital40